{"created":"2023-05-15T14:47:32.580358+00:00","id":65188,"links":{},"metadata":{"_buckets":{"deposit":"d9331255-6e5f-42e5-b436-c904798ed229"},"_deposit":{"created_by":1,"id":"65188","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"65188"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00065188","sets":["10:29"]},"author_link":["642229"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2013-09-20","subitem_date_issued_type":"Issued"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"神経疾患の分子プローブによるイメージング及び標的治療に関する新しい進展","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Takahashi, Kazuhiro"}],"nameIdentifiers":[{"nameIdentifier":"642229","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"64Cu-DOTA-trastuzumab-PET imaging in patients with HER2-positive breast cancer","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"64Cu-DOTA-trastuzumab-PET imaging in patients with HER2-positive breast cancer"}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2013-10-16"},"publish_date":"2013-10-16","publish_status":"0","recid":"65188","relation_version_is_last":true,"title":["64Cu-DOTA-trastuzumab-PET imaging in patients with HER2-positive breast cancer"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T21:02:59.239286+00:00"}